AOD Thesaurus.  Annotated Hierarchy.  diseases.  GJ - GN10.8.4
b-out  To Broad Outline    d-out  To Detailed Outline     qh  To Quick Hierarchy
Previous Annotated Hierarchy section    Next Annotated Hierarchy section     Search



GJedevelopmental disorder   d-out   qh
NT GZ6.6 psychosis originating in childhood    qh   ah
RT GA2.8.2.6 developmental disability    qh   ah
+GY2e developmental delay    qh   ah

GJ2eintrauterine disorder   qh
ST prenatal disorders
RT+ED4.10e prenatal development    qh   ah
+ESe reproductive function    qh   ah
+GH18e genetic disorder    qh   ah
 GJ2.16.2.2.2 neonatal abstinence syndrome    qh   ah
+GJ4.2e congenital anomaly    qh   ah
+GRe metabolic disorder    qh   ah
GJ2.2e.  prenatal nutritional deficiency   qh
BT+GH14e nutritional disorder    qh   ah
+GH14.4e nutritional deficiency    qh   ah
GJ2.4.  poor fetal development   qh
BT+ED4.10e prenatal development    qh   ah
RT+GJ2.16.2.4e alcohol-related intrauterine disorder    qh   ah
+GJ6e growth and development disorder    qh   ah
GJ2.6e.  fetal distress syndrome   qh
SN A change in the fetal heart rate, especially slowing, accompanied by meconium in the amniotic fluid. These signs usually indicate fetal anoxia.
RT EM2.2 fetal breathing movements    qh   ah
 GJ2.16.2.4.2e fetal alcohol effects    qh   ah
GJ2.6.2.  .  fetal aspiration syndrome   qh
SN The entry of amniotic fluid into the bronchial tubes in excessive amounts due to premature and violent efforts to breathe by the distressed fetus in the uterus.
ST meconium aspiration pneumonia
GJ2.8e.  miscarriage   qh
ST spontaneous abortion
BT+ED4.14e pregnancy outcome    qh   ah
RT+PB6.10 fertility rate    qh   ah
GJ2.10e.  stillbirth   qh
HN Introduced 1995. ETOH descriptor 2000.
BT+ED4.14e pregnancy outcome    qh   ah
GJ2.12e.  low birth weight   qh
BT+EA10.8.2e birth weight    qh   ah
RT+ED4.14e pregnancy outcome    qh   ah
+JA6 risk and protective factors    qh   ah
+JA6.12.6 biological risk and protective factors    qh   ah
GJ2.14e.  teratogenesis   qh
SN The origin or mechanism of production of a developmentally abnormal embryo, fetus, postnatal individual, or part thereof.
ST abnormal embryogenesis
dysmorphogenesis
teratism
teratosis
NT GJ2.18.2 infectious teratogenesis    qh   ah
BT+EE14.4.4.4.2.8 irreversible toxic effect    qh   ah
RT+EE20.6e prenatal chemical exposure    qh   ah
+EX10.2e mutagenesis    qh   ah
 GH18.4e mutagenic disorder    qh   ah
+XE2.2e embryo    qh   ah
+XE2.4e fetus    qh   ah
GJ2.14.2.  .  chemical teratogenesis   qh
SN Use for alcohol or other drug exposure leading to abnormal fetal development.
BT+GH10 exogenous chemical disorder    qh   ah
+GH10.4 chemical poisoning    qh   ah
RT ED4.12e pregnancy    qh   ah
+EE14.4.4.4.2e toxic drug effect    qh   ah
+EE20.6e prenatal chemical exposure    qh   ah
GJ2.16e.  chemical intrauterine disorder   qh
SN Intrauterine disorders are often a result of teratogenesis.
BT+GH10.4 chemical poisoning    qh   ah
+GJ4.2e congenital anomaly    qh   ah
RT+Be AOD substance or product    qh   ah
 ED4.10.4e fetal development    qh   ah
+EE20.6e prenatal chemical exposure    qh   ah
 GA2.8.2.6 developmental disability    qh   ah
 HD2.4.2e morphometric analysis    qh   ah
GJ2.16.2.  .  AODR intrauterine disorder   qh
HN Introduced 1995.
BT+GDe AODR disorder    qh   ah
RT ED4.12e pregnancy    qh   ah
+EE20.4e reproductive effects of AODU    qh   ah
GJ2.16.2.2e.  .  .  AODR neonatal disorder   qh
BT+GDe AODR disorder    qh   ah
GJ2.16.2.2.2.  .  .  .  neonatal abstinence syndrome   qh
ST neonatal AOD abstinence syndrome
RT+EE20.6e prenatal chemical exposure    qh   ah
+GJ2e intrauterine disorder    qh   ah
GJ2.16.2.4e.  .  .  alcohol-related intrauterine disorder   qh
HN Introduced 2000.
SN The subdivision follows diagnostic categories proposed by the Institute of Medicine.
BT+XE2.4e fetus    qh   ah
RT+ED4.10.2.2e embryogenesis    qh   ah
 GJ2.4 poor fetal development    qh   ah
+GJ4.2e congenital anomaly    qh   ah
+GJ4.2.4.2.2e congenital facial anomaly    qh   ah
+GJ4.2.10e neurodevelopmental anomaly    qh   ah
+GN2.2e congenital heart anomaly    qh   ah
+GWe sensory system disorder    qh   ah
 GX8.2 anencephaly    qh   ah
+GY6e mental retardation    qh   ah
+GZ2 mental symptom    qh   ah
 YJ8e nerve growth factors    qh   ah
 ZU10.8.4e retinoic acid    qh   ah
GJ2.16.2.4.2e.  .  .  .  fetal alcohol effects   qh
SN Use this term when the effects of alcohol use on the fetus are not as profound or pronounced as in fetal alcohol syndrome (FAS).
ST alcohol related birth defects
ARBD
FAE
BT+GDe AODR disorder    qh   ah
+GD4 alcohol related disorder    qh   ah
RT CK10.2e free radicals    qh   ah
 EE20.4.2.2 maternal alcohol exposure    qh   ah
 EE20.4.4.2 paternal alcohol exposure    qh   ah
 EE20.6.4.2e prenatal alcohol exposure    qh   ah
 GC18.10.4e maternal alcoholism    qh   ah
+GJ2.6e fetal distress syndrome    qh   ah
+GJ2.16.2.4.6e fetal alcohol syndrome    qh   ah
GJ2.16.2.4.4e.  .  .  .  alcohol-related neurodevelopmental disorder   qh
HN Introduced 2000.
BT+GJ4.2.10e neurodevelopmental anomaly    qh   ah
GJ2.16.2.4.6e.  .  .  .  fetal alcohol syndrome   qh
SN A pattern of retarded growth and development, both mental and physical, with cranial, facial, limb, and cardiovascular defects, found in some children of mothers whose alcohol consumption during pregnancy can be classified as hazardous. The most common abnormalities are prenatal and postnatal growth deficiency, microcephaly, developmental delay or mental retardation, short palpebral fissures, a short upturned nose with sunken nasal bridge and thin upper lip, abnormal palmar creases, and cardiac (especially septal) defects. Many other, more subtle abnormalities also have been attributed to the effects of alcohol on the fetus (see *GJ2.16.2.4.2 fetal alcohol effects* qh ah), but there is controversy regarding the level of maternal consumption that produces such effects.
      FAS is associated with increased frequency of infections, especially during the first two years of life.
ST FAS
RT EE20.6.4.2e prenatal alcohol exposure    qh   ah
+GZ2.22e behavioral problem    qh   ah
 HE2.2e computer-based morphometric analysis    qh   ah
+XTe immune system    qh   ah
GJ2.16.2.4.6.2.  .  .  .  .  partial FAS with confirmed maternal alcohol exposure   qh
HN Introduced 2000.
GJ2.16.2.4.6.4.  .  .  .  .  FAS without confirmed maternal alcohol exposure   qh
HN Introduced 2000.
GJ2.16.2.4.6.6.  .  .  .  .  FAS with confirmed maternal alcohol exposure   qh
HN Introduced 2000.
GJ2.16.2.6.  .  .  tobacco-related intrauterine disorder   qh
GJ2.16.2.8.  .  .  cocaine-related intrauterine disorder   qh
GJ2.16.2.8.2.  .  .  .  crack baby   qh
GJ2.18.  infectious intrauterine disorder   qh
BT+GH16e communicable disease    qh   ah
+GJ4.2e congenital anomaly    qh   ah
GJ2.18.2.  .  infectious teratogenesis   qh
BT+GJ2.14e teratogenesis    qh   ah
RT GH16.12.12 rubella    qh   ah
 GH16.18.2.10 toxoplasmosis    qh   ah
GJ2.18.4.  .  congenital infection   qh
RT GH16.12.20.2.2e acquired immunodeficiency syndrome    qh   ah
 GH16.14.18 gonorrhea    qh   ah
 GH16.14.24.6 syphilis    qh   ah

GJ4ebirth defects   qh
HN Introduced 2000.
SN Any abnormality present at birth, particularly a structural one that may be inherited, acquired during gestation, or inflicted during birth.
GJ4.2e.  congenital anomaly   qh
SN Condition that originated prenatally and was manifest at birth. Often includes neurological and neurochemical dysfunctions.
SN Anomalous malformations, diseases, etc., which may be either hereditary or due to an influence occurring during gestation up to the moment of birth.
ST congenital defects
congenital malformation
malformations
NT+GJ2.16e chemical intrauterine disorder    qh   ah
+GJ2.18 infectious intrauterine disorder    qh   ah
+GX8 congenital nervous system disorder    qh   ah
RT+GH18e genetic disorder    qh   ah
+GJ2e intrauterine disorder    qh   ah
+GJ2.16.2.4e alcohol-related intrauterine disorder    qh   ah
+GT2.16 congenital blood disorder    qh   ah
GJ4.2.2.  .  neonatal jaundice   qh
GJ4.2.4e.  .  congenital morphologic anomaly   qh
RT HD2.4.2e morphometric analysis    qh   ah
+Xe body part    qh   ah
GJ4.2.4.2e.  .  .  congenital musculoskeletal anomaly   qh
BT+GLe musculoskeletal and connective tissue disorder    qh   ah
+GL4 musculoskeletal deformity    qh   ah
GJ4.2.4.2.2e.  .  .  .  congenital facial anomaly   qh
ST congenital craniofacial abnormality
congenital craniofacial anomaly
BT+GL4.2e craniofacial anomaly    qh   ah
RT+GJ2.16.2.4e alcohol-related intrauterine disorder    qh   ah
GJ4.2.4.2.2.2e.  .  .  .  .  cleft palate   qh
HN Changed descriptor 2000; through 1999 use "cleft lip." ETOH descriptor 2000.
ST cleft lip
GJ4.2.4.6e.  .  .  spina bifida   qh
HN ETOH descriptor 2000.
GJ4.2.6.  .  congenital visceral anomaly   qh
NT+GN2e congenital cardiovascular anomaly    qh   ah
GJ4.2.8.  .  congenital functional anomaly   qh
RT+ESe reproductive function    qh   ah
GJ4.2.10e.  .  neurodevelopmental anomaly   qh
NT GJ2.16.2.4.4e alcohol-related neurodevelopmental disorder    qh   ah
RT+GJ2.16.2.4e alcohol-related intrauterine disorder    qh   ah
+GY6e mental retardation    qh   ah
GJ4.2.10.2e.  .  .  Down's syndrome   qh
HN ETOH descriptor 2000.
ST mongolism
RT+GY6e mental retardation    qh   ah
+GZe behavioral and mental disorder    qh   ah
GJ4.4e.  connatal disorder   qh
HN ETOH descriptor 2000.
SN Anomaly or disorder originating or acquired at birth.
GJ4.4.2.  .  birth injury   qh

GJ6egrowth and development disorder   qh
RT+EE14.4.4.4e adverse drug effect    qh   ah
+GG20e abnormal growth and differentiation    qh   ah
 GJ2.4 poor fetal development    qh   ah
GJ6.2e.  growth retardation   qh
GJ6.4.  pediatric disorder   qh
GJ6.6.  juvenile disorder   qh
GJ6.8.  geriatric disorder   qh
NT+GZ6.2.4.2 senile dementia    qh   ah
GJ6.10.  premature aging   qh
HN Introduced 2000.
BT+ED6.4e aging    qh   ah


GKdisorder by body system or organ function   d-out   qh
NT+GLe musculoskeletal and connective tissue disorder    qh   ah
+GMe skin disorder    qh   ah
+GNe cardiovascular disorder    qh   ah
+GOe respiratory disorder    qh   ah
+GPe oral disorder    qh   ah
+GQe digestive system disorder    qh   ah
+GRe metabolic disorder    qh   ah
+GSe urogenital disorder    qh   ah
+GTe blood system disorder    qh   ah
+GUe immune disorder    qh   ah
+GVe endocrine disorder    qh   ah
+GWe sensory system disorder    qh   ah
+GW4e sensory nerve disorder    qh   ah
+GXe nervous system disorder    qh   ah
+GYe disorder of higher mental process    qh   ah
+GZe behavioral and mental disorder    qh   ah
RT+AMe AOD effects and consequences    qh   ah
+EA10e biological structure    qh   ah
+EH body system or organ function    qh   ah
+Xe body part    qh   ah

GLemusculoskeletal and connective tissue disorder   d-out   qh
NT+GJ4.2.4.2e congenital musculoskeletal anomaly    qh   ah
BT+GK disorder by body system or organ function    qh   ah
+XGe musculoskeletal system    qh   ah
RT+EA14 biological movement    qh   ah
+EJe musculoskeletal function    qh   ah
+GH6e trauma    qh   ah
GL2.  musculoskeletal symptom   qh
BT+EJe musculoskeletal function    qh   ah
RT+GXe nervous system disorder    qh   ah
GL2.2e.  .  abnormal involuntary movement   qh
RT+EA14 biological movement    qh   ah
+GX6.12 degenerative motor system disorder    qh   ah
+GY2.4e motor skills disorder    qh   ah
GL2.2.2e.  .  .  tremor   qh
GL2.2.4e.  .  .  spasm   qh
GL2.4e.  .  impaired balance and coordination   qh
HN Introduced 2000.
ST incoordination
poor balance and coordination
RT+GZ2.6 psychomotor symptom    qh   ah
GL2.4.4.  .  .  impaired motor coordination   qh
HN Introduced 2000.
BT+EJ14e motor coordination    qh   ah
+GA2.8e impaired health    qh   ah
GL2.4.4.2e.  .  .  .  ataxia   qh
SN Gross muscular incoordination like that which can occur with alcohol intoxication.
ST lack of coordination
muscular incoordination
RT+EA14 biological movement    qh   ah
 EJ6e body balance    qh   ah
+EJ14e motor coordination    qh   ah
+GX6.12 degenerative motor system disorder    qh   ah
 GY2.4.2 developmental coordination disorder    qh   ah
GL2.4.4.2.2.  .  .  .  .  gait abnormality   qh
RT+EA14 biological movement    qh   ah
+EJ8e locomotion    qh   ah
GL2.6.  .  meningismus   qh
SN A group of symptoms and signs suggesting meningitis that may occur in the absence of any identifiable pathologic lesion of the meninges. The major manifestations are headache and neck stiffness. The syndrome usually occurs in children suffering from febrile infections such as pneumonia, tonsillitis, and systemic viral infections. Also called Dupre's disease.
GL2.8.  .  tetany   qh
SN A syndrome marked by a state of neuromuscular hyperexcitability.
RT+EJ14e motor coordination    qh   ah
 EW10.2e neuromuscular function    qh   ah
 GH16.14.6 tetanus    qh   ah
GL4.  musculoskeletal deformity   qh
NT+GJ4.2.4.2e congenital musculoskeletal anomaly    qh   ah
RT EA10.2 body physical characteristic    qh   ah
+GG8 distortion or displacement of body part    qh   ah
 GL14.20 acquired skeletal deformity    qh   ah
GL4.2e.  .  craniofacial anomaly   qh
HN Introduced 2000.
ST craniofacial abnormality
NT+GJ4.2.4.2.2e congenital facial anomaly    qh   ah
GL6e.  muscular disorder   qh
NT GH16.12.2 chronic fatigue syndrome    qh   ah
RT+EJ10e muscle function    qh   ah
 GL12 rheumatism    qh   ah
 GY8.4.2 dysarthria    qh   ah
GL6.2.  .  muscular dystrophy   qh
BT+GRe metabolic disorder    qh   ah
GL6.4.  .  myopathy   qh
NT+GN8.8.4e cardiomyopathy    qh   ah
GL6.4.6e.  .  .  AODR myopathy   qh
SN A disorder of skeletal muscle related to the use of alcohol or other drugs. The disorder can be acute (when it is termed "acute rhabdomyolysis"), with extensive necrosis of muscles, which are tender and swollen, and may be complicated by myoglobinuria and renal failure. The chronic form presents with insidious weakness and wasting of the proximal muscles.
BT+GDe AODR disorder    qh   ah
GL6.4.6.2.  .  .  .  alcoholic myopathy   qh
NT GN8.8.4.6e alcoholic cardiomyopathy    qh   ah
BT+GD4 alcohol related disorder    qh   ah
GL8.  joint symptom   qh
GL8.8.  .  arthralgia   qh
GL10.  arthropathy   qh
ST joint diseases
RT+GL16 connective tissue disorder    qh   ah
GL10.2.  .  infectious arthropathy   qh
ST infectious joint disease
BT+GH16e communicable disease    qh   ah
GL10.4.  .  crystal arthropathy   qh
ST arthritis
inflammatory joint disease
GL10.6.  .  inflammatory polyarthropathy   qh
ST Felty's syndrome
polyarthritis
GL10.6.2.  .  .  rheumatoid arthritis   qh
BT+GU6e autoimmune disorder    qh   ah
GL10.8.  .  osteoarthrosis   qh
GL10.12.  .  dorsopathy   qh
GL12.  rheumatism   qh
RT+GL6e muscular disorder    qh   ah
GL14.  osteopathy, chondropathy, acquired deformity   qh
GL14.2.  .  bone infection   qh
ST bone abscess
BT+GG16.6e infection    qh   ah
GL14.2.4.  .  .  osteomyelitis   qh
GL14.8e.  .  osteoporosis   qh
RT+EB28.2e calcium metabolism    qh   ah
GL14.10.  .  osteomalacia   qh
RT+EB28.2e calcium metabolism    qh   ah
GL14.12e.  .  osteopenia   qh
HN Introduced 2000.
GL14.14.  .  pathological fracture   qh
BT+GG6 disruption of structural integrity    qh   ah
+GH6.2.6.8e bone fracture    qh   ah
GL14.16.  .  aseptic necrosis of bone   qh
ST osteonecrosis
BT+GG14.6e necrosis    qh   ah
GL14.20.  .  acquired skeletal deformity   qh
RT+GL4 musculoskeletal deformity    qh   ah
GL16.  connective tissue disorder   qh
RT+GL10 arthropathy    qh   ah
GL16.8.  .  systemic lupus erythematosus   qh
ST SLE
BT+GU6e autoimmune disorder    qh   ah
RT+GM4.12 erythematous condition    qh   ah

GMeskin disorder   d-out   qh
ST integumentary disease
BT+GK disorder by body system or organ function    qh   ah
+XH skin system    qh   ah
RT+EKe skin function    qh   ah
+EV12.2 skin sense    qh   ah
+GU2.6 skin hypersensitivity    qh   ah
GM2.  skin infection   qh
NT GH16.12.8.4 genital herpes    qh   ah
BT+GG16.6e infection    qh   ah
RT+GH16e communicable disease    qh   ah
GM2.6.  .  impetigo   qh
ST pemphigus neonatorum
GM4e.  skin inflammation   qh
BT+GG16.4e inflammation    qh   ah
GM4.2.  .  dermatosis   qh
GM4.4.  .  atopic dermatitis   qh
BT+GU2.4 atopy    qh   ah
+GU2.6 skin hypersensitivity    qh   ah
GM4.6.  .  contact dermatitis   qh
BT+GU2.6 skin hypersensitivity    qh   ah
GM4.8e.  .  eczema   qh
BT+GU2.6 skin hypersensitivity    qh   ah
GM4.10.  .  bullous dermatoses   qh
GM4.12.  .  erythematous condition   qh
RT GL16.8 systemic lupus erythematosus    qh   ah
GM4.12.2.  .  .  acne   qh
GM4.14e.  .  psoriasis   qh
GM4.16.  .  lichen planus   qh
GM4.18.  .  pruritus   qh
GM4.20.  .  urticaria   qh
ST hives
GM6.  skin pigmentation disorder   qh
ST dyschromia
RT GF2.8 pigmentation    qh   ah
GM8.  nail disorder   qh
GM10.  hair and hair follicle disorder   qh
GM12.  sweat gland disorder   qh
RT XB2.8.10e sweat    qh   ah

GNecardiovascular disorder   d-out   qh
BT+GK disorder by body system or organ function    qh   ah
+XJe cardiovascular system    qh   ah
RT+ELe cardiovascular system function    qh   ah
+HG6 cardiovascular diagnosis    qh   ah
GN2e.  congenital cardiovascular anomaly   qh
BT+GJ4.2.6 congenital visceral anomaly    qh   ah
GN2.2e.  .  congenital heart anomaly   qh
BT+GN8e heart disorder    qh   ah
RT+GJ2.16.2.4e alcohol-related intrauterine disorder    qh   ah
GN2.2.4.  .  .  Fallot's tetralogy   qh
GN2.4.  .  coarctation of aorta   qh
BT+GN10.4.4e vascular stenosis    qh   ah
GN2.6.  .  patent ductus arteriosus   qh
RT HV6.16.2e surgical vascular shunts    qh   ah
GN4e.  sudden infant death syndrome   qh
HN ETOH descriptor 2000.
SN The cause is unknown, although it is most likely due to dysfunction of neural cardiovascular control mechanisms.
ST COT death
crib death
SIDS
RT GA2.8.6.4.4 functional failure    qh   ah
+GO4 apnea    qh   ah
GN6e.  circulatory disorder   qh
RT+EL2e blood circulation    qh   ah
GN6.2e.  .  hypertensive disorder   qh
RT EL4.8e blood pressure    qh   ah
GN6.2.2.  .  .  vascular hypertension   qh
ST high blood pressure
hypertension
GN6.2.2.2.  .  .  .  pulmonary hypertension   qh
BT+GO16e lung disorder    qh   ah
RT EL2.4 pulmonary blood circulation    qh   ah
 GN6.4.4.6 cor pulmonale    qh   ah
GN6.2.2.4.  .  .  .  systemic hypertension   qh
RT+EL2.2 systemic blood circulation    qh   ah
GN6.2.2.4.2e.  .  .  .  .  portal hypertension   qh
HN ETOH descriptor 2000.
RT+GQ4.12e esophageal varix    qh   ah
+GQ10.6e chronic liver disease    qh   ah
GN6.2.4.  .  .  essential hypertension   qh
ST idiopathic hypertension
primary hypertension
GN6.2.6.  .  .  endocrinal hypertension   qh
BT+GVe endocrine disorder    qh   ah
RT+XUe endocrine system    qh   ah
+YH2.4.6e angiotensin    qh   ah
GN6.2.6.4.  .  .  .  renal hypertension   qh
ST renin-dependent hypertension
BT+GS2.2e kidney disorder    qh   ah
RT+XP2e kidney    qh   ah
GN6.4e.  .  cardiocirculatory collapse   qh
GN6.4.2.  .  .  hypotension and shock   qh
GN6.4.2.2.  .  .  .  hypotension   qh
GN6.4.2.4.  .  .  .  hypovolemic shock   qh
RT GR20.10 dehydration    qh   ah
GN6.4.2.6.  .  .  .  cardiogenic shock   qh
RT GN6.10.2.4e myocardial infarction    qh   ah
GN6.4.2.8.  .  .  .  neurogenic shock   qh
RT+XY6.4.4e sympathetic nervous system    qh   ah
GN6.4.4.  .  .  cardiac insufficiency   qh
BT+GN8e heart disorder    qh   ah
RT+XJ4e heart    qh   ah
GN6.4.4.2.  .  .  .  heart overload   qh
ST cardiac overload
GN6.4.4.4e.  .  .  .  heart failure   qh
HN ETOH descriptor 2000.
RT GN6.4.6e cardiac enlargement    qh   ah
 GN6.6e cardiac decompensation    qh   ah
GN6.4.4.4.2e.  .  .  .  .  congestive heart failure   qh
HN ETOH descriptor 2000.
SN Progressive inability of a diseased heart to pump sufficient blood to meet the demands of the body.
GN6.4.4.6.  .  .  .  cor pulmonale   qh
RT GN6.2.2.2 pulmonary hypertension    qh   ah
GN6.4.6e.  .  .  cardiac enlargement   qh
HN ETOH descriptor 2000.
ST cardiac hypertrophy
RT+GN6.4.4.4e heart failure    qh   ah
+GN8.8.4e cardiomyopathy    qh   ah
+XJ4e heart    qh   ah
GN6.6e.  .  cardiac decompensation   qh
HN Introduced 2000.
SN A condition in which the heart cannot pump enough blood to meet the body's normal requirements.
RT+GN6.4.4.4e heart failure    qh   ah
GN6.8.  .  cardiac tamponade   qh
RT XJ2e pericardium    qh   ah
GN6.10e.  .  vascular ischemia   qh
SN Deficiency of blood in an organ or tissue, usually due to constriction or blockage of a blood vessel. May result in a lack of oxygen (hypoxia).
ST circulatory hypoxia
ischemia
vascular hypoxia
BT+GF2.12e hypoxia    qh   ah
RT+GN10.4e vascular obstruction    qh   ah
+GN10.4.6e atherosclerosis    qh   ah
 GT2.14e thrombosis    qh   ah
+GX4.12e cerebral vascular disorder    qh   ah
+XF body system or organ    qh   ah
GN6.10.2e.  .  .  myocardial ischemia   qh
HN Changed descriptor 2000; through 1999 use "myocardial ischemia or hypoxia."
ST ischemic heart disease
BT+GF2.12e hypoxia    qh   ah
+GN8.8e myocardial disorder    qh   ah
GN6.10.2.2e.  .  .  .  coronary artery disorder   qh
GN6.10.2.2.2e.  .  .  .  .  angina pectoris   qh
SN A spasmodic, choking, or suffocating pain that usually accompanies ischemia in the myocardium.
ST angina
angor pectoris
GN6.10.2.4e.  .  .  .  myocardial infarction   qh
ST AMI
heart attack
BT+GN6.14e cardiovascular deterioration    qh   ah
RT+GG14.6e necrosis    qh   ah
 GN6.4.2.6 cardiogenic shock    qh   ah
GN6.12.  .  natural vascular shunt   qh
SN Use for congenital (vascular communication) or physiological shunts. Use *GG10.8.2 artificial shunt* qh ah for man-made vascular shunts.
BT+GG10.8 change of transit or circulation    qh   ah
RT GG10.8.2 artificial shunt    qh   ah
GN6.14e.  .  cardiovascular deterioration   qh
ST cardiovascular weakness
NT GN6.10.2.4e myocardial infarction    qh   ah
+GN8.8.4e cardiomyopathy    qh   ah
GN6.14.2e.  .  .  aneurysm   qh
BT+GG14e deterioration of body part    qh   ah
+GN8.8e myocardial disorder    qh   ah
+GN10.6.2e vascular dilation    qh   ah
RT XJ4.4.2e myocardium    qh   ah
+XJ6e blood vessel    qh   ah
 XJ6.2.2.2e aorta    qh   ah
GN8e.  heart disorder   qh
ST cardiac disorder
cardiopathy
coronary heart disease
heart disease
NT+GN2.2e congenital heart anomaly    qh   ah
+GN6.4.4 cardiac insufficiency    qh   ah
BT+XJ4e heart    qh   ah
RT+EL4e heart function    qh   ah
GN8.2.  .  heart murmur   qh
GN8.4e.  .  cardiac conduction disorder   qh
ST cardiac conduction disturbance
RT+XJ4.4.8 cardiac conduction system    qh   ah
GN8.4.6e.  .  .  cardiac arrhythmia   qh
ST cardiac rhythm disorder
cardiac rhythm disturbance
dysrhythmia
GN8.4.6.2.  .  .  .  bradycardia   qh
RT+HG6 cardiovascular diagnosis    qh   ah
GN8.4.6.4e.  .  .  .  tachycardia   qh
HN ETOH descriptor 1995.
RT+HG6 cardiovascular diagnosis    qh   ah
GN8.4.6.6.  .  .  .  flutter   qh
GN8.4.6.8e.  .  .  .  cardiac fibrillation   qh
HN Changed descriptor 2000; through 1999 use "fibrillation." ETOH descriptor 2000.
GN8.4.6.8.2e.  .  .  .  .  atrial fibrillation   qh
HN Introduced 2000.
SN Loss of coordinated contraction of either or both atria.
GN8.4.6.8.4e.  .  .  .  .  ventricular fibrillation   qh
HN Introduced 2000.
SN The rapid and uncoordinated contraction of the muscle fibers of the ventricle, a pumping chamber of the heart, resulting in a twitching, rather than contraction, of the ventricle.
GN8.4.8.  .  .  heart block   qh
GN8.4.10e.  .  .  heart arrest   qh
HN ETOH descriptor 2000.
ST cardiac arrest
GN8.4.10.2.  .  .  .  sudden cardiac death   qh
ST sudden death
GN8.6.  .  cardiac valve disorder   qh
ST valvular heart disease
RT+XJ4.8e heart valve    qh   ah
 XJ4.8.2.2 mitral valve    qh   ah
GN8.6.2.  .  .  cardiac valve stenosis   qh
GN8.6.4.  .  .  cardiac valve insufficiency   qh
GN8.8e.  .  myocardial disorder   qh
ST heart muscle disorder
NT+GN6.10.2e myocardial ischemia    qh   ah
 GN6.14.2e aneurysm    qh   ah
GN8.8.4e.  .  .  cardiomyopathy   qh
SN A general term for primary noninflammatory disease of the myocardium.
BT+GL6.4 myopathy    qh   ah
+GN6.14e cardiovascular deterioration    qh   ah
RT GN6.4.6e cardiac enlargement    qh   ah
GN8.8.4.2.  .  .  .  hypertrophic cardiomyopathy   qh
GN8.8.4.4.  .  .  .  dilated cardiomyopathy   qh
SN A form of cardiomyopathy in which one or more chambers of the heart are abnormally distended with blood.
RT GN8.8.4.6e alcoholic cardiomyopathy    qh   ah
GN8.8.4.6e.  .  .  .  alcoholic cardiomyopathy   qh
HN ETOH descriptor 1995.
SN A diffuse disorder of heart muscle seen in individuals with a history of hazardous alcohol consumption, usually of at least 10 years' duration. Patients typically present with biventricular heart failure. Common symptoms include shortness of breath on exertion and while recumbent (nocturnal dyspnea), palpitations, ankle edema, and abdominal distension due to ascites. Disturbance of cardiac rhythm is usual; atrial fibrillation is the most frequent arrhythmia.
      It should be distinguished from beri-beri heart failure and a form of "beer drinkers' cardiomyopathy" due to cobalt poisoning.
ST alcoholic heart muscle disease
BT+GD4 alcohol related disorder    qh   ah
+GL6.4.6.2 alcoholic myopathy    qh   ah
RT GN8.8.4.4 dilated cardiomyopathy    qh   ah
GN8.10.  .  cardiac inflammation or infection   qh
BT+GG16 inflammation or infection    qh   ah
RT+GH16e communicable disease    qh   ah
+WAe virus    qh   ah
+WDe bacteria    qh   ah
+XJ4.8e heart valve    qh   ah
GN10e.  vascular disorder   qh
NT+GX4.12e cerebral vascular disorder    qh   ah
RT GT2.14e thrombosis    qh   ah
+XJ6e blood vessel    qh   ah
GN10.2e.  .  vascular rupture   qh
RT+GH6e trauma    qh   ah
GN10.2.2e.  .  .  hemorrhage   qh
RT+GT2.6e anemia    qh   ah
+GX4.12.2e stroke    qh   ah
 GX4.12.6e cerebral hemorrhage    qh   ah
GN10.2.2.2e.  .  .  .  variceal hemorrhage   qh
RT GQ4.12.2 bleeding esophageal varix    qh   ah
GN10.2.4.  .  .  hematoma   qh
RT GX4.12.8 cerebral hematoma    qh   ah
GN10.4e.  .  vascular obstruction   qh
RT+GN6.10e vascular ischemia    qh   ah
GN10.4.2.  .  .  vasospasm   qh
GN10.4.4e.  .  .  vascular stenosis   qh
HN ETOH descriptor 1995.
ST vascular constriction
vascular narrowing
NT GN2.4 coarctation of aorta    qh   ah
GN10.4.6e.  .  .  atherosclerosis   qh
SN A condition in which deposition of materials, often fat droplets, in the walls of arteries leads to narrowing and hardening of the arteries.
RT+GN6.10e vascular ischemia    qh   ah
GN10.4.6.2e.  .  .  .  arteriosclerosis   qh
HN ETOH descriptor 2000.
GN10.6.  .  vascular dilation or proliferation   qh
GN10.6.2e.  .  .  vascular dilation   qh
HN Introduced 1995.
NT GN6.14.2e aneurysm    qh   ah
GN10.6.2.2.  .  .  .  varicose veins   qh
NT+GQ4.12e esophageal varix    qh   ah
GN10.6.4.  .  .  vascular proliferation   qh
HN Introduced 1995.
GN10.8.  .  vascular inflammation or infection   qh
ST angiitis
vasculitis
BT+GG16 inflammation or infection    qh   ah
RT+GH16e communicable disease    qh   ah
GN10.8.2.  .  .  phlebitis   qh
GN10.8.2.2.  .  .  .  thrombophlebitis   qh
RT GT2.14e thrombosis    qh   ah
GN10.8.4.  .  .  arteritis   qh


b-out  To Broad Outline    d-out  To Detailed Outline     qh  To Quick Hierarchy
Previous Annotated Hierarchy section    Next Annotated Hierarchy section     Search

classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept